All posts by: Michael Zand

About Michael Zand

This Spanish Biotech Is Developing Stem-Cell Targeted Leukemia Treatments – Labiotech.eu (blog)

Continue reading

2018-03-02 NEWS

Labiotech.eu (blog)

This Spanish Biotech Is Developing StemCell Targeted Leukemia Treatments
Labiotech.eu (blog)
Leukos’ lead project is a diagnosis kit based on Phase IIa data. Additional projects in the pipeline target other blood cancers. Comment: I was surprised to learn that although remission rates for AML patients after chemotherapy range from 50-85%, the

Continue reading

2018-03-02 NEWS

Ten Eyewitness News

Stem cell breakthrough as scientists develop mini-kidney
Ten Eyewitness News
Researchers from Melbourne and the Netherlands have moved one step closer to making human kidneys from stem cells, after they successfully transferred a mini-kidney grown in a lab into a living mouse. Scientists at Murdoch Children’s Research Institute
Lab-grown kidneys a step closer after Melbourne-Dutch researchers’ breakthroughHerald Sun

all 2 news articles »

Continue reading

2018-03-01 NEWS

Medscape

Is Aspirin the New (Old) Immunotherapy?
Medscape
For those of you who follow me on Medscape and WebMD, you know that I don’t like aspirin: I love it. I think it’s a wonderful drug. There’s a lot of work going on just now looking at its molecular pharmacology. There’s a great recent paper published by

Continue reading

2018-03-01 NEWS

New Mesothelioma Treatment Combines Immunotherapy and Targeted Radiation
Surviving Mesothelioma
Researchers at one of the nation’s top cancer institutes are betting on a combination of radiation and immunotherapy in the continued pursuit of better treatments for malignant mesothelioma. Memorial Sloan Kettering in New York is now recruiting